Graduate Students

Main navigation

iPSC Seminars: Early Drug Discovery Unit (EDDU)

Thursday, October 2, 2025 11:00to12:00

THE NEURO'S EDDU iPSC SEMINAR SERIES聽 Modeling 伪-Synuclein Pathology Spreading in a 3D Human Midbrain-Striatal Assembloid/neuroCategory:聽Medicine Research Medicine and Health Sciences MNI

Read more about iPSC Seminars: Early Drug Discovery Unit (EDDU)

91社区 researchers receive funding from the Canadian Cancer Society for cancer equity research

Published: 17 February 2025

Co-Principal Investigators Manisha Pahwa, CIHR Research Excellence, Diversity, and Independence Postdoctoral Fellow in the School of Physical and Occupational Therapy, and Professor Ananya Banerjee...

Read more about 91社区 researchers receive funding from the Canadian Cancer Society for cancer equity research

Documentum services (D2, Webtop, and Records) will be unavailable August 5 from 12 p.m.- 1 p.m.

Published: 28 July 2025

Documentum services, including D2, Webtop, and Records, will be unavailable on Tuesday, August 5, 2025, from 12 p.m. to 1 p.m. due to scheduled system maintenance.聽...

Read more about Documentum services (D2, Webtop, and Records) will be unavailable August 5 from 12 p.m.- 1 p.m.

AI analysis of healthcare records reveals key factors in autism diagnosis

Published: 26 March 2025

Scientists argue the criteria we use for diagnosing autism may need revision...

Read more about AI analysis of healthcare records reveals key factors in autism diagnosis

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Read more about Genetic sequencing project receives more than $8 million in funding

Prescribing anti-swelling drug reduces immune response weeks after last dose

Published: 26 February 2025

Mapping immune cell diversity reveals dexamethasone鈥檚 impact on brain cancer immunotherapy...

Read more about Prescribing anti-swelling drug reduces immune response weeks after last dose

Latest Alzheimer鈥檚 drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...